• RIOCIGUAT CHEMBL2107834 FDA Approved

    Alternate Names:

    Riociguat
    METHYL N-[4,6-DIAMINO-2-[1-[(2-FLUOROPHENYL)METHYL]PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL]-N-METHYL-CARBAMATE
    METHYL {4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}METHYLCARBAMATE
    CARBAMIC ACID, N-(4,6-DIAMINO-2-(1-((2-FLUOROPHENYL)METHYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL)-5-PYRIMIDINYL)-N-METHYL-, METHYL ESTER
    CARBAMIC ACID, (4,6-DIAMINO-2-(1-((2-FLUOROPHENYL)METHYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL)-5-PYRIMIDINYL)METHYL-, METHYL ESTER
    I14-16377
    BAY 63-2521; BAY 632521
    Q-4478
    D09572
    X6629
    ST1171165
    AB0033159
    BCP0726000023
    KB-80378
    HY-14779
    HE367522
    HE067864
    AK172141
    PB25734
    CS-0584
    BCP9000382
    ACN-036668
    AKOS015900718
    CR0020
    AN-401
    RIOCIGUAT,CAS:625115-55-1
    ZINC3819392
    WXXSNCNJFUAIDG-UHFFFAOYSA-N
    QCR-167
    RIOCIGUAT (BAY 63-2521)
    C20H19FN8O2
    GTPL5257
    SCHEMBL245457
    RIOCIGUAT [USAN:INN:JAN]
    BAY 63-2521,RIOCIGUAT
    RU3FE2Y4XI
    RIOCIGUAT (JAN/INN)
    ADEMPAS (TN)
    METHYL N-(4,6-DIAMINO-2-{1-[(2-FLUOROPHENYL)METHYL]-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL}PYRIMIDIN-5-YL)-N-METHYLCARBAMATE
    METHYL 4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]-5-PYRIMIDINYL(METHYL)CARBAMATE
    METHYL 4,6-DIAMINO-2-(1-(2-FLUOROBENZYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL)-5-PYRIMIDINYL(METHYL)CARBAMATE
    ADEMPASREG
    RIOCIGUATUM
    N-[4,6-DIAMINO-2-[1-[(2-FLUOROPHENYL)METHYL]-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]-5-PYRIMIDINYL]-N-METHYLCARBAMIC ACID METHYL ESTER
    METHYL N-(4,6-DIAMINO-2-{1-((2-FLUOROPHENYL)METHYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL}PYRIMIDIN-5-YL)-N-METHYLCARBAMATE
    [4,6-DIAMINO-2-[1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL]METHYLCARBAMIC ACID METHYL ESTER
    METHYL (4,6-DIAMINO-2-(1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)PYRIMIDIN-5-YL)(METHYL)CARBAMATE
    CHEBI:76018
    UNII-RU3FE2Y4XI
    ADEMPAS
    625115-55-1
    11304743
    178101941
    5257
    Methyl N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methyl-carbaminate
    DB08931

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications antihypertensive agent
    Drug Categories hypotensive agents
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories guanylate cyclase
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp2c8 substrates
    Drug Categories cardiovascular system
    Drug Categories bcrp/abcg2 substrates
    Drug Categories azoles
    Drug Categories antihypertensives for pulmonary arterial hypertension
    Drug Categories antihypertensive agents
    Drug Groups approved
    Drug Type small molecule
    (1 More Sources)